Profile
Debra K.
Bowes founded Chevy Chase BioPartners LLC in 2006, where she worked as President from 2006 to 2022.
Ms. Bowes also formerly worked at Capgenesis Pharma, Inc., as President & Chief Executive Officer, MedImmune LLC, as Senior Director-Strategic Planning from 2003 to 2006, MaxCyte, Inc., as Executive VP-Business & Strategic Development from 2016 to 2019, Cleveland BioLabs, Inc., as Vice President-Business Development from 2011 to 2013, Women in Bio, Inc., as National President, and Omeros Corp., as Chief Business Development Officer.
Ms. Bowes received her graduate degree from The Johns Hopkins University and undergraduate degree from the University of Cincinnati (Ohio).
Former positions of Debra K. Bowes
| Companies | Position | End |
|---|---|---|
| OMEROS CORPORATION | Corporate Officer/Principal | 2023-10-31 |
| Chevy Chase BioPartners LLC | Founder | 2021-12-31 |
| MAXCYTE, INC. | Corporate Officer/Principal | 2018-12-31 |
| STATERA BIOPHARMA, INC. | Corporate Officer/Principal | 2012-12-31 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2005-12-31 |
Training of Debra K. Bowes
| The Johns Hopkins University | Graduate Degree |
| University of Cincinnati (Ohio) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| MAXCYTE, INC. | Health Technology |
| Private companies | 5 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Commercial Services |
| Capgenesis Pharma, Inc. | |
| Chevy Chase BioPartners LLC |
- Stock Market
- Insiders
- Debra K. Bowes
